Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Besse

Showing results (201-210 of 512) with videos related to

Pageof 52
Sort By:
Pharmaceutical Research|March 26, 2026
Hospital-Compounded Birabresib Capsules for NUT Carcinoma: A Quality- and Risk-Based CMC StrategyMaxime Annereau, François-Xavier Legrand, Maria Virginia Sánchez-Becerra, et al.
Lung Cancer (Amsterdam, Netherlands)|December 22, 2011
Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancerBenjamin Besse, David Planchard, Anne-Sophie Veillard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2019
Defining Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Systematic ReviewNiccolò Giaj-Levra, Matteo Giaj-Levra, Valerie Durieux, et al.
JCO Clinical Cancer Informatics|July 1, 2021
Natural Language Processing for Patient Selection in Phase I or II Oncology Clinical TrialsJulie Delorme, Valentin Charvet, Muriel Wartelle, et al.
Clinical and Experimental Immunology|September 8, 2025
Expanded senescent CD8 T cells in IMID patients are associated with distinct inflammatory cytokinesMarie Naigeon, Samuel Bitoun, Matthieu Roulleaux Dugage, et al.
Lung Cancer (Amsterdam, Netherlands)|February 17, 2005
Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar featuresMustafa Erman, Dominique Grunenwald, Frederique Penault-Llorca, et al.
Journal of the National Cancer Institute|April 10, 2025
Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC: a reconstructed individual patient data meta-analysisAntonio Nuccio, Fabio Salomone, Alberto Servetto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2007
Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancerPierre Saintigny, Benjamin Besse, Patrice Callard, et al.
JAMA Oncology|June 12, 2020
Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for Non-Small Cell Lung CancerBaptiste Kas, Hugues Talbot, Roberto Ferrara, et al.
Future Oncology (London, England)|December 16, 2021
MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancerByoung Chul Cho, Enriqueta Felip, Hidetoshi Hayashi, et al.
Pageof 52

Showing results (201-210 of 512) with videos related to

Sort By:
Pageof 52
Pharmaceutical Research|March 26, 2026
Hospital-Compounded Birabresib Capsules for NUT Carcinoma: A Quality- and Risk-Based CMC StrategyMaxime Annereau, François-Xavier Legrand, Maria Virginia Sánchez-Becerra, et al.
Lung Cancer (Amsterdam, Netherlands)|December 22, 2011
Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancerBenjamin Besse, David Planchard, Anne-Sophie Veillard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2019
Defining Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Systematic ReviewNiccolò Giaj-Levra, Matteo Giaj-Levra, Valerie Durieux, et al.
JCO Clinical Cancer Informatics|July 1, 2021
Natural Language Processing for Patient Selection in Phase I or II Oncology Clinical TrialsJulie Delorme, Valentin Charvet, Muriel Wartelle, et al.
Clinical and Experimental Immunology|September 8, 2025
Expanded senescent CD8 T cells in IMID patients are associated with distinct inflammatory cytokinesMarie Naigeon, Samuel Bitoun, Matthieu Roulleaux Dugage, et al.
Lung Cancer (Amsterdam, Netherlands)|February 17, 2005
Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar featuresMustafa Erman, Dominique Grunenwald, Frederique Penault-Llorca, et al.
Journal of the National Cancer Institute|April 10, 2025
Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC: a reconstructed individual patient data meta-analysisAntonio Nuccio, Fabio Salomone, Alberto Servetto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2007
Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancerPierre Saintigny, Benjamin Besse, Patrice Callard, et al.
JAMA Oncology|June 12, 2020
Clarification of Definitions of Hyperprogressive Disease During Immunotherapy for Non-Small Cell Lung CancerBaptiste Kas, Hugues Talbot, Roberto Ferrara, et al.
Future Oncology (London, England)|December 16, 2021
MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancerByoung Chul Cho, Enriqueta Felip, Hidetoshi Hayashi, et al.
Pageof 52